0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PD-L1 Biomarker Testing Platform Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-14J5904
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global PD L1 Biomarker Testing Platform Market Insights and Forecast to 2028
BUY CHAPTERS

Global PD-L1 Biomarker Testing Platform Market Research Report 2024

Code: QYRE-Auto-14J5904
Report
January 2024
Pages:69
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

PD-L1 Biomarker Testing Platform Market Size

The global PD-L1 Biomarker Testing Platform market was valued at US$ 1470 million in 2023 and is anticipated to reach US$ 2018.3 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030.

PD-L1 Biomarker Testing Platform Market

PD-L1 Biomarker Testing Platform Market

PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.
North American market for PD-L1 Biomarker Testing Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for PD-L1 Biomarker Testing Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for PD-L1 Biomarker Testing Platform in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of PD-L1 Biomarker Testing Platform include Agilent Technologies and Roche etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PD-L1 Biomarker Testing Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-L1 Biomarker Testing Platform.

Report Scope

The PD-L1 Biomarker Testing Platform market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PD-L1 Biomarker Testing Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PD-L1 Biomarker Testing Platform companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of PD-L1 Biomarker Testing Platform Market Report

Report Metric Details
Report Name PD-L1 Biomarker Testing Platform Market
Accounted market size in 2023 US$ 1470 million
Forecasted market size in 2030 US$ 2018.3 million
CAGR 4.7%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • PD-L1(22C3)
  • PD-L1(28-8)
  • PD-L1(SP142)
  • PD-L1(SP263)
  • Other
Segment by Application
  • Hospital
  • Diagnostic Center
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Agilent Technologies, Roche
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of PD-L1 Biomarker Testing Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is PD-L1 Biomarker Testing Platform Market growing?

Ans: The PD-L1 Biomarker Testing Platform Market witnessing a CAGR of 4.7% during the forecast period 2024-2030.

What is the PD-L1 Biomarker Testing Platform Market size in 2030?

Ans: The PD-L1 Biomarker Testing Platform Market size in 2030 will be US$ 2018.3 million.

Who are the main players in the PD-L1 Biomarker Testing Platform Market report?

Ans: The main players in the PD-L1 Biomarker Testing Platform Market are Agilent Technologies, Roche

What are the Application segmentation covered in the PD-L1 Biomarker Testing Platform Market report?

Ans: The Applications covered in the PD-L1 Biomarker Testing Platform Market report are Hospital, Diagnostic Center, Other

What are the Type segmentation covered in the PD-L1 Biomarker Testing Platform Market report?

Ans: The Types covered in the PD-L1 Biomarker Testing Platform Market report are PD-L1(22C3), PD-L1(28-8), PD-L1(SP142), PD-L1(SP263), Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PD-L1 Biomarker Testing Platform Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PD-L1(22C3)
1.2.3 PD-L1(28-8)
1.2.4 PD-L1(SP142)
1.2.5 PD-L1(SP263)
1.2.6 Other
1.3 Market by Application
1.3.1 Global PD-L1 Biomarker Testing Platform Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PD-L1 Biomarker Testing Platform Market Perspective (2019-2030)
2.2 PD-L1 Biomarker Testing Platform Growth Trends by Region
2.2.1 Global PD-L1 Biomarker Testing Platform Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 PD-L1 Biomarker Testing Platform Historic Market Size by Region (2019-2024)
2.2.3 PD-L1 Biomarker Testing Platform Forecasted Market Size by Region (2025-2030)
2.3 PD-L1 Biomarker Testing Platform Market Dynamics
2.3.1 PD-L1 Biomarker Testing Platform Industry Trends
2.3.2 PD-L1 Biomarker Testing Platform Market Drivers
2.3.3 PD-L1 Biomarker Testing Platform Market Challenges
2.3.4 PD-L1 Biomarker Testing Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PD-L1 Biomarker Testing Platform Players by Revenue
3.1.1 Global Top PD-L1 Biomarker Testing Platform Players by Revenue (2019-2024)
3.1.2 Global PD-L1 Biomarker Testing Platform Revenue Market Share by Players (2019-2024)
3.2 Global PD-L1 Biomarker Testing Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PD-L1 Biomarker Testing Platform Revenue
3.4 Global PD-L1 Biomarker Testing Platform Market Concentration Ratio
3.4.1 Global PD-L1 Biomarker Testing Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PD-L1 Biomarker Testing Platform Revenue in 2023
3.5 PD-L1 Biomarker Testing Platform Key Players Head office and Area Served
3.6 Key Players PD-L1 Biomarker Testing Platform Product Solution and Service
3.7 Date of Enter into PD-L1 Biomarker Testing Platform Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PD-L1 Biomarker Testing Platform Breakdown Data by Type
4.1 Global PD-L1 Biomarker Testing Platform Historic Market Size by Type (2019-2024)
4.2 Global PD-L1 Biomarker Testing Platform Forecasted Market Size by Type (2025-2030)
5 PD-L1 Biomarker Testing Platform Breakdown Data by Application
5.1 Global PD-L1 Biomarker Testing Platform Historic Market Size by Application (2019-2024)
5.2 Global PD-L1 Biomarker Testing Platform Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America PD-L1 Biomarker Testing Platform Market Size (2019-2030)
6.2 North America PD-L1 Biomarker Testing Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America PD-L1 Biomarker Testing Platform Market Size by Country (2019-2024)
6.4 North America PD-L1 Biomarker Testing Platform Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PD-L1 Biomarker Testing Platform Market Size (2019-2030)
7.2 Europe PD-L1 Biomarker Testing Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe PD-L1 Biomarker Testing Platform Market Size by Country (2019-2024)
7.4 Europe PD-L1 Biomarker Testing Platform Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PD-L1 Biomarker Testing Platform Market Size (2019-2030)
8.2 Asia-Pacific PD-L1 Biomarker Testing Platform Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific PD-L1 Biomarker Testing Platform Market Size by Region (2019-2024)
8.4 Asia-Pacific PD-L1 Biomarker Testing Platform Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PD-L1 Biomarker Testing Platform Market Size (2019-2030)
9.2 Latin America PD-L1 Biomarker Testing Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America PD-L1 Biomarker Testing Platform Market Size by Country (2019-2024)
9.4 Latin America PD-L1 Biomarker Testing Platform Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PD-L1 Biomarker Testing Platform Market Size (2019-2030)
10.2 Middle East & Africa PD-L1 Biomarker Testing Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa PD-L1 Biomarker Testing Platform Market Size by Country (2019-2024)
10.4 Middle East & Africa PD-L1 Biomarker Testing Platform Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies PD-L1 Biomarker Testing Platform Introduction
11.1.4 Agilent Technologies Revenue in PD-L1 Biomarker Testing Platform Business (2019-2024)
11.1.5 Agilent Technologies Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche PD-L1 Biomarker Testing Platform Introduction
11.2.4 Roche Revenue in PD-L1 Biomarker Testing Platform Business (2019-2024)
11.2.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global PD-L1 Biomarker Testing Platform Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of PD-L1(22C3)
    Table 3. Key Players of PD-L1(28-8)
    Table 4. Key Players of PD-L1(SP142)
    Table 5. Key Players of PD-L1(SP263)
    Table 6. Key Players of Other
    Table 7. Global PD-L1 Biomarker Testing Platform Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global PD-L1 Biomarker Testing Platform Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global PD-L1 Biomarker Testing Platform Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global PD-L1 Biomarker Testing Platform Market Share by Region (2019-2024)
    Table 11. Global PD-L1 Biomarker Testing Platform Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global PD-L1 Biomarker Testing Platform Market Share by Region (2025-2030)
    Table 13. PD-L1 Biomarker Testing Platform Market Trends
    Table 14. PD-L1 Biomarker Testing Platform Market Drivers
    Table 15. PD-L1 Biomarker Testing Platform Market Challenges
    Table 16. PD-L1 Biomarker Testing Platform Market Restraints
    Table 17. Global PD-L1 Biomarker Testing Platform Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global PD-L1 Biomarker Testing Platform Market Share by Players (2019-2024)
    Table 19. Global Top PD-L1 Biomarker Testing Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing Platform as of 2023)
    Table 20. Ranking of Global Top PD-L1 Biomarker Testing Platform Companies by Revenue (US$ Million) in 2023
    Table 21. Global 5 Largest Players Market Share by PD-L1 Biomarker Testing Platform Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players PD-L1 Biomarker Testing Platform Product Solution and Service
    Table 24. Date of Enter into PD-L1 Biomarker Testing Platform Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global PD-L1 Biomarker Testing Platform Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global PD-L1 Biomarker Testing Platform Revenue Market Share by Type (2019-2024)
    Table 28. Global PD-L1 Biomarker Testing Platform Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global PD-L1 Biomarker Testing Platform Revenue Market Share by Type (2025-2030)
    Table 30. Global PD-L1 Biomarker Testing Platform Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global PD-L1 Biomarker Testing Platform Revenue Market Share by Application (2019-2024)
    Table 32. Global PD-L1 Biomarker Testing Platform Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global PD-L1 Biomarker Testing Platform Revenue Market Share by Application (2025-2030)
    Table 34. North America PD-L1 Biomarker Testing Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. North America PD-L1 Biomarker Testing Platform Market Size by Country (2019-2024) & (US$ Million)
    Table 36. North America PD-L1 Biomarker Testing Platform Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Europe PD-L1 Biomarker Testing Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Europe PD-L1 Biomarker Testing Platform Market Size by Country (2019-2024) & (US$ Million)
    Table 39. Europe PD-L1 Biomarker Testing Platform Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Asia-Pacific PD-L1 Biomarker Testing Platform Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Asia-Pacific PD-L1 Biomarker Testing Platform Market Size by Region (2019-2024) & (US$ Million)
    Table 42. Asia-Pacific PD-L1 Biomarker Testing Platform Market Size by Region (2025-2030) & (US$ Million)
    Table 43. Latin America PD-L1 Biomarker Testing Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Latin America PD-L1 Biomarker Testing Platform Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Latin America PD-L1 Biomarker Testing Platform Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Middle East & Africa PD-L1 Biomarker Testing Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Middle East & Africa PD-L1 Biomarker Testing Platform Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Middle East & Africa PD-L1 Biomarker Testing Platform Market Size by Country (2025-2030) & (US$ Million)
    Table 49. Agilent Technologies Company Detail
    Table 50. Agilent Technologies Business Overview
    Table 51. Agilent Technologies PD-L1 Biomarker Testing Platform Product
    Table 52. Agilent Technologies Revenue in PD-L1 Biomarker Testing Platform Business (2019-2024) & (US$ Million)
    Table 53. Agilent Technologies Recent Development
    Table 54. Roche Company Detail
    Table 55. Roche Business Overview
    Table 56. Roche PD-L1 Biomarker Testing Platform Product
    Table 57. Roche Revenue in PD-L1 Biomarker Testing Platform Business (2019-2024) & (US$ Million)
    Table 58. Roche Recent Development
    Table 59. Research Programs/Design for This Report
    Table 60. Key Data Information from Secondary Sources
    Table 61. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global PD-L1 Biomarker Testing Platform Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global PD-L1 Biomarker Testing Platform Market Share by Type: 2023 VS 2030
    Figure 3. PD-L1(22C3) Features
    Figure 4. PD-L1(28-8) Features
    Figure 5. PD-L1(SP142) Features
    Figure 6. PD-L1(SP263) Features
    Figure 7. Other Features
    Figure 8. Global PD-L1 Biomarker Testing Platform Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global PD-L1 Biomarker Testing Platform Market Share by Application: 2023 VS 2030
    Figure 10. Hospital Case Studies
    Figure 11. Diagnostic Center Case Studies
    Figure 12. Other Case Studies
    Figure 13. PD-L1 Biomarker Testing Platform Report Years Considered
    Figure 14. Global PD-L1 Biomarker Testing Platform Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global PD-L1 Biomarker Testing Platform Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global PD-L1 Biomarker Testing Platform Market Share by Region: 2023 VS 2030
    Figure 17. Global PD-L1 Biomarker Testing Platform Market Share by Players in 2023
    Figure 18. Global Top PD-L1 Biomarker Testing Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing Platform as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by PD-L1 Biomarker Testing Platform Revenue in 2023
    Figure 20. North America PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America PD-L1 Biomarker Testing Platform Market Share by Country (2019-2030)
    Figure 22. United States PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe PD-L1 Biomarker Testing Platform Market Share by Country (2019-2030)
    Figure 26. Germany PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific PD-L1 Biomarker Testing Platform Market Share by Region (2019-2030)
    Figure 34. China PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America PD-L1 Biomarker Testing Platform Market Share by Country (2019-2030)
    Figure 42. Mexico PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa PD-L1 Biomarker Testing Platform Market Share by Country (2019-2030)
    Figure 46. Turkey PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia PD-L1 Biomarker Testing Platform Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Agilent Technologies Revenue Growth Rate in PD-L1 Biomarker Testing Platform Business (2019-2024)
    Figure 49. Roche Revenue Growth Rate in PD-L1 Biomarker Testing Platform Business (2019-2024)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS